These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33355252)

  • 21. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness.
    Greenland S; Mansournia MA
    Eur J Epidemiol; 2015 Oct; 30(10):1101-10. PubMed ID: 25687168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causal inference for clinicians.
    Stovitz SD; Shrier I
    BMJ Evid Based Med; 2019 Jun; 24(3):109-112. PubMed ID: 30765385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causal Inference Methods for Estimating Long-Term Health Effects of Air Quality Regulations.
    Zigler CM; Kim C; Choirat C; Hansen JB; Wang Y; Hund L; Samet J; King G; Dominici F;
    Res Rep Health Eff Inst; 2016 May; (187):5-49. PubMed ID: 27526497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causal inference, probability theory, and graphical insights.
    Baker SG
    Stat Med; 2013 Nov; 32(25):4319-30. PubMed ID: 23661231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive models aren't for causal inference.
    Arif S; MacNeil MA
    Ecol Lett; 2022 Aug; 25(8):1741-1745. PubMed ID: 35672133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Triangulation WIthin a STudy (TWIST) framework for causal inference within pharmacogenetic research.
    Bowden J; Pilling LC; Türkmen D; Kuo CL; Melzer D
    PLoS Genet; 2021 Sep; 17(9):e1009783. PubMed ID: 34495953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causal Diagrams: Pitfalls and Tips.
    Suzuki E; Shinozaki T; Yamamoto E
    J Epidemiol; 2020 Apr; 30(4):153-162. PubMed ID: 32009103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causality and causal inference in epidemiology: the need for a pluralistic approach.
    Vandenbroucke JP; Broadbent A; Pearce N
    Int J Epidemiol; 2016 Dec; 45(6):1776-1786. PubMed ID: 26800751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic Causal Inference Using Genome-Wide Association Study Data: Mendelian Randomization and Beyond.
    Walker VM; Zheng J; Gaunt TR; Smith GD
    Annu Rev Biomed Data Sci; 2022 Aug; 5():1-17. PubMed ID: 35363507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational research--opportunities and limitations.
    Boyko EJ
    J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related.
    Weed DL
    Int J Epidemiol; 2000 Jun; 29(3):387-90. PubMed ID: 10869307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can synthetic controls improve causal inference in interrupted time series evaluations of public health interventions?
    Degli Esposti M; Spreckelsen T; Gasparrini A; Wiebe DJ; Bonander C; Yakubovich AR; Humphreys DK
    Int J Epidemiol; 2021 Jan; 49(6):2010-2020. PubMed ID: 33005920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, analysis, and conclusions: Telling a consistent causal story.
    Harpe SE
    Curr Pharm Teach Learn; 2017; 9(1):121-136. PubMed ID: 29180145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Causal Diagrams to Improve the Design and Interpretation of Medical Research.
    Etminan M; Collins GS; Mansournia MA
    Chest; 2020 Jul; 158(1S):S21-S28. PubMed ID: 32658648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary: Using potential outcomes causal methods to assess whether reductions in PM
    Goodman JE; Li W; Cox LA
    Glob Epidemiol; 2021 Nov; 3():100052. PubMed ID: 37635718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there causal relationships between attention-deficit/hyperactivity disorder and body mass index? Evidence from multiple genetically informed designs.
    Liu CY; Schoeler T; Davies NM; Peyre H; Lim KX; Barker ED; Llewellyn C; Dudbridge F; Pingault JB
    Int J Epidemiol; 2021 May; 50(2):496-509. PubMed ID: 33221865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of covariate selection for non-experimental comparative effectiveness research.
    Sauer BC; Brookhart MA; Roy J; VanderWeele T
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1139-45. PubMed ID: 24006330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are neighborhoods causal? Complications arising from the 'stickiness' of ZNA.
    Glass TA; Bilal U
    Soc Sci Med; 2016 Oct; 166():244-253. PubMed ID: 26830654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.